Non-antiarrhythmic drugs to prevent atrial fibrillation.
Folkeringa
Richard J
RJ
Department of Cardiology and CARIM, University and University Hospital Maastricht, The Netherlands.
Tieleman
Robert G
RG
Crijns
Harry J G M
HJ
D000804:Angiotensin II / Q000037:antagonists & inhibitors / Q000378:metabolism; D047228:Angiotensin II Type 1 Receptor Blockers / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D001281:Atrial Fibrillation / Q000188:drug therapy / Q000517:prevention & control*; D002316:Cardiotonic Agents / Q000145:classification / Q000627:therapeutic use*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use; D011322:Primary Prevention
D047228:Angiotensin II Type 1 Receptor Blockers; D002316:Cardiotonic Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000804:Angiotensin II